Orion Pharma Limited (DSE:ORIONPHARM)
Bangladesh · Delayed Price · Currency is BDT 28.60
-0.10 (-0.35%)
At close: Aug 13, 2026
Orion Pharma Market Cap
Orion Pharma has a market cap or net worth of 6.69 billion as of August 14, 2026. Its market cap has decreased by -4.98% in one year.
Market Cap
6.69B
Enterprise Value
35.00B
Revenue
3.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
28.60
ChartMarket Cap Chart
Since March 20, 2013, Orion Pharma's market cap has decreased from 14.66B to 6.69B, a decrease of -54.36%. That is a compound annual growth rate of -5.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 6.69B | 4.38% |
| Dec 30, 2025 | 6.41B | -27.70% |
| Dec 30, 2024 | 8.87B | -52.39% |
| Dec 28, 2023 | 18.63B | -3.75% |
| Dec 29, 2022 | 19.35B | -9.22% |
| Dec 30, 2021 | 21.32B | 66.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beacon Pharmaceuticals | 25.02B |
| The ACME Laboratories | 17.58B |
| Asiatic Laboratories | 14.36B |
| The IBN SINA Pharmaceutical Industry | 10.03B |
| Navana Pharmaceuticals | 7.45B |
| Techno Drugs | 5.98B |
| Indo-Bangla Pharmaceuticals | 2.24B |
| Silva Pharmaceuticals | 2.21B |